Clinical Research Directory
Browse clinical research sites, groups, and studies.
HeartMed-HF Digital Therapeutics Improves Exercise Capacity in CHF Patients After AMI
Sponsor: The First Affiliated Hospital with Nanjing Medical University
Summary
Chronic heart failure (HF) is a severe manifestation and terminal stage of various cardiovascular diseases, with high incidence and mortality rates. Myocardial infarction (MI) is currently one of the most common and significant causes of HF globally. The occurrence of HF after MI significantly increases the mortality risk for patients. Actively controlling risk factors and strengthening outpatient management of HF patients post-MI are crucial for alleviating clinical symptoms and enhancing exercise capacity. Recently, digital health interventions (DHI) have shown promising potential in managing cardiovascular disease patients. However, the application in patients with HF post-MI has not been well-reported. Therefore, this study independently and innovatively designed the HeartMed-HF digital therapeutics to demonstrate its effectiveness and safety in patients with HF after MI.
Official title: HeartMed-HF Digital Therapeutics Improves Exercise Capacity in Patients With Chronic Heart Failure After Acute Myocardial Infarction: an International, Multi-center, Randomized Controlled Clinical Trial
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
710
Start Date
2024-07-30
Completion Date
2026-12-31
Last Updated
2024-07-16
Healthy Volunteers
No
Conditions
Interventions
health services
Implement comprehensive heart failure management for patients in the experimental group using the HeartMed-HF digital therapy